SMALL INTESTINAL BACTERIAL OVERGROWTH

This adverse event was reported 59 times

SMALL INTESTINAL BACTERIAL OVERGROWTH is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SACROSIDASE 1 0.0055
1 ALOSETRON HYDROCHLORIDE 1 0.0012
2 PSYLLIUM HUSK 1 0.0007
3 CLOMIPHENE CITRATE 1 0.0007
4 NEOMYCIN OINTMENT 1 0.0004
5 LEVONORGESTREL AND ETHINYL ESTRADIOL 1 0.0004
6 METAXALONE 1 0.0003
7 IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE 1 0.0002
8 DEXMETHYLPHENIDATE HYDROCHLORIDE 1 0.0002
9 SALINE NASAL SPRAY 1 0.0002
See all drugs enriched for association with SMALL INTESTINAL BACTERIAL OVERGROWTH

SMALL INTESTINAL BACTERIAL OVERGROWTH is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Sucrose-specific Enzyme [EPC] 1 0.0055
1 Photoenhancer [EPC] 1 0.0003
2 GLP-2 Analog [EPC] 3 0.0002
3 Ergot Derivative [EPC] 1 0.0002
4 Human Immunoglobulin G [EPC] 3 0.0001
5 Provitamin D2 Compound [EPC] 4 0.0001
6 Rifamycin Antibacterial [EPC] 4 0.0001
7 Bile Acid Sequestrant [EPC] 1 0.0001
8 Potassium-sparing Diuretic [EPC] 1 0.0001
9 Nicotinic Acid [EPC] 4 0.0001
See all drug classes enriched for association with SMALL INTESTINAL BACTERIAL OVERGROWTH